Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1987-02-18
1989-05-30
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
A61K 31275
Patent
active
048351814
ABSTRACT:
This invention provides certain 4-substituted benzamide derivatives, their pharmaceutical formulations, and their use as anticonvulsant agents.
REFERENCES:
patent: 4004029 (1977-01-01), Collins et al.
patent: 4379165 (1983-04-01), Clark
patent: 4386031 (1983-05-01), Hilboll et al.
patent: 4629740 (1986-12-01), Robertson
patent: 4638014 (1987-01-01), Clark
Chem. Abst., 11th Collective Formulas, C.sub.16 H.sub.14 NOS.sub.2 --C.sub.18 H.sub.14 V.sub.2 refers to (1984).
Chem. Abst. 91 (1979)-168209c.
Stout et al., J. Med. Chem., 28, 295 (1985).
Rodriguez-Salazar, J. Pharm. Sci., 63, 158 (1974).
Goerdeler et al., Chem. Ber., 110, 2996 (1977).
Grammaticakis, Bull. Soc. Chim. France, 924 (1964), (CA 61:5488a).
Grammaticakis, Bull, Soc. Chim., France, 862 (1963), (CA 59:5945f).
Beedle Edward E.
Robertson David W.
Conrad Robert A.
Eli Lilly and Company
Friedman Stanley J.
Whitaker Leroy
LandOfFree
Anticonvulsant agents using cyano dimethylphenyl benzamides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anticonvulsant agents using cyano dimethylphenyl benzamides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anticonvulsant agents using cyano dimethylphenyl benzamides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2152968